Armata Pharmaceuticals ARMP
NYSE ARMP
$3.68 +0.09 (+2.51%)
As of: Sep 30, 2026 · 3:55 PM EDT

Armata Pharmaceuticals (ARMP) Capital Expenditures (2013 - 2026)

Updated

Armata Pharmaceuticals' Capital Expenditures came in at $17,000 for Q2 2026, down 88.6% from $149,000 a year earlier and down 73.0% from the prior quarter.

Analysis

Armata Pharmaceuticals (ARMP) Capital Expenditures (2013 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Armata Pharmaceuticals reported Capital Expenditures of $374,000, down 26.8% year-over-year; for FY2025, it was $542,000, down 71.2% from FY2024.

  • Capital Expenditures carries a five-year compound annual growth rate of -8.0% (FY2020 to FY2025).
  • Going back by year, Capital Expenditures was $1.88 million in FY2024 (-76.9%), $8.14 million in FY2023 (+268.3%), $2.21 million in FY2022 (+69.6%) and $1.3 million in FY2021 (+58.3%).
  • The Q2 2026 figure represents the lowest quarterly Capital Expenditures since Q4 2024.
  • The fastest year-over-year change in Capital Expenditures over five years came in Q1 2023 (growth of 751.7%), and the weakest in Q3 2024 (a decline of 90.3%).
  • Business Quant data shows ARMP's Capital Expenditures at $63,000 (Q1 2026), $52,000 (Q4 2025) and $242,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Armata Pharmaceuticals 133.35 Mn 81.07 Mn - 17,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17,000.00
Mar 31, 2026 63,000.00
Dec 31, 2025 52,000.00
Sep 30, 2025 242,000.00
Jun 30, 2025 149,000.00
Mar 31, 2025 99,000.00
Dec 31, 2024 -77,000.00
Sep 30, 2024 340,000.00
Jun 30, 2024 1.37 Mn
Mar 31, 2024 250,000.00
Dec 31, 2023 2.40 Mn
Sep 30, 2023 3.51 Mn
Jun 30, 2023 222,000.00
Mar 31, 2023 2.01 Mn
Dec 31, 2022 -455,000.00
Sep 30, 2022 1.29 Mn
Jun 30, 2022 1.14 Mn
Mar 31, 2022 236,000.00
Dec 31, 2021 228,000.00
Sep 30, 2021 582,000.00
API Access

Armata Pharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ARMP&period=max&api_key=YOUR_API_KEY